CMBA
IDYA icon

C.M. Bidwell & Associates’s IDEAYA Biosciences IDYA Stock Holding History

C.M. Bidwell & Associates’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-100
Closed -$2.35K – 552
2023
Q2 		$2.35K Sell
100
-25
-20% -$514 ﹤0.01% 454
2023
Q1 		$1.72K Buy
+125
New +$2.08K ﹤0.01% 481

Other funds holding IDYA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

C.M. Bidwell & Associates's IDYA Position: Q3 2023 in Review

C.M. Bidwell & Associates sold out of IDEAYA Biosciences (IDYA) in Q3 2023, closing a stake of 100 shares — an estimated $2.35K sold.

C.M. Bidwell & Associates first reported a position in IDYA in Q1 2023 and held it in 2 quarters. The position peaked at $2.35K in Q2 2023. 144 funds tracked by Wall St. Rank hold IDYA as of Q3 2023.

  • C.M. Bidwell & Associates reported no remaining IDEAYA Biosciences position as of Q3 2023 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 100 IDEAYA Biosciences shares in Q3 2023, an estimated $2.35K.
  • C.M. Bidwell & Associates first reported a position in IDEAYA Biosciences in Q1 2023 and held it in 2 quarters.
  • C.M. Bidwell & Associates's IDEAYA Biosciences position peaked at $2.35K in Q2 2023.
  • 144 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2023.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2023, filed 13 Nov 2023.